Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Clinical trial NCT01750281 · COMPLETED

Trial details

NCT number

NCT01750281

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-12-18

Primary completion

2016-01-27

Enrollment

212

View on ClinicalTrials.gov